Retrieve Medical Holdings Inc. (OTC:RMHI) Stock In Focus After Recent News

This morning, investors are going to be looking into those companies that were in the news cycle on Monday, and by that token, it is likely that the Retrieve Medical Holdings Inc. (OTC:RMHI) stock is going to be in focus. Yesterday, the company came into focus after it announced a major new milestone in its growth trajectory.

The company announced that Retrieve Medical Inc., its fully owned subsidiary unit, had inked a crucial contract for the deployment of its advanced software at one of the more prominent hospitals in Louisiana. It was a significant new development for the company since it charted further expansion of Retrieve Medical into the healthcare industry.

The latest development would also boost the company’s portfolio due to its collaboration with a reputed community healthcare system. By way of this collaboration, the company’s proprietary software solution, Retrieve Dx, would be implemented on a two-hospital healthcare system campus consisting of as many as 150 beds. It serves more than 44,000 emergency department visitors on an annual basis.

In the news release, the company noted that the Case Mix Index (CMI) was a major driver of the dynamic American healthcare reimbursement space. However, it was absolutely essential to boost the documentation of co-morbidities among the admitted patients so as to optimize CMI. The innovative platform from the company helps physicians with the task of streamlining the identification of co-morbidities.

Eventually, the platform would also help in the identification of those co-morbidities and their integration into the medical records of patients with accuracy. The chairman of the company, Dr. Mark Rosenberg, spoke about the development as well. He noted that everyone at the company was pleased about the possibility of reaching into another community health system. He went on to add that it also reinforced the company’s position as the preferred physician documentation software provider for medical systems and hospitals.

Ian Leigh

Ian Leigh is a specialist in analyzing stocks, SEC and OTC filings, and financials of public and privately-held companies. He has played a significant role in M&A activity, consulting with publicly-held firms on acquisitions and divestitures. He also consults on valuations and branding. He lectures at major universities and teaches at specialty financial schools.